| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.07 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.07 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.058 | 0.07 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | -0.085 | 0.07 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | -0.087 | 0.07 |
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | -0.063 | 0.07 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.07 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.057 | 0.07 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.07 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.069 | 0.08 |